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Introduction

The immune system consists (in part) of cells and their products that protect the body
from attack by infectious agents. Without this vital system, the body would soon succumb to one
or more of these death-causing agents. Fortunately, the immune system eliminates many of these
infectious agents before there is any sign of infection. One of the most important groups of cells
in this system are the T lymphocytes, or T cells. A specific subset of T cells called cytotoxic T
lyniphocytes, or CTLs, are responsible for surveying the cell surfaces for foreign substances.
Upon recognition of one of these foreign antigens, the T cell becomes activated and kills the cell
expressing the antigen. Cells express foreign antigens when infected by foreign microorganisms,
(i.e. pathogens) or when they have turned cancerous. The CTL then, is involved in protecting the
body from intracellular pathogens and from the development of tumors.
The purpose of this project is to gain a better understanding of allorecognition by T cells
through the use of an alloreactive T cell receptor. (In short, allorecognition is the recognition of
several molecules by a single T cell receptor.) This understanding will also help us to better'
understand the positive selection of T cells that occurs during fetal thymic development. During
fetal development, immature T cells in the thymus are stimulated to continue development or die,
depending upon their ability to recognize class I MIlC molecules contained in the thymus (1).
Class I MIlC molecules are antigen-presenting molecules that are necessary for immune
recognition by T cells. The process of positive selection leads to a population of self-MIlC
restricted T cells that will recognize peptides only in the context of a class I MIlC molecule that
was present during development. Occasionally, however, a T cell has the ability to recognize one
or more non-self class I MIlC molecules that are not normally present in the body. This ability to
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recognize one or more non-selfMHC molecule(s) that somehow resembles the selfMHC
molecule is called alloreactivity (2). In some cases, the difference between the training (self)
molecule and the allo-molecule (non-self) is a single amino acid substitution, while in other cases,
the sequences differ extensively.
Michelle Tallquist, a graduate student at the Mayo Graduate School in Rochester
Minnesota, and I worked with the Kbm3 and Ld alleles of the murine class I major
histocompatibility complex. These alleles differ at virtually every polymorphic amino acid
position within the antigen binding cleft and along the a. helices of the MHC molecule
(3,4)(Figure 1). The mechanism by which a single T cell receptor (TCR) is able to recognize two
or more MHC molecules is not understood. We believe that there is some difference. in the
orientation of the TCR contact on the MHC/peptide complexes resulting in a change of epitopes
(i.e. the portion of the complex recognized) and important contact residues. By selectively
mutating several points in the two MHC molecules, we hope to disrupt recognition by altering an
important contact residue in one molecule, while not affecting recognition of the other molecule.
This result would lead to a better understanding of alloreactivity and positive selection.
Class I MHC Structure
Class I MHC molecules are transmembrane glycoproteins that occur on the surface of all
nucleated cells in the body (with the exception of sperm and trophoblast) and play an important
role in antigen presentation (1). Each molecule contains a cytoplasmic domain, a transmembrane
domain as an anchor, and three extracellular domains (1 )(Figure 2). Crystallographic evidence
reveals that the important extracellular domains include two membrane-proximal,
immunoglobulin-like domains, termed beta-2 microglobulin (~2M) and alpha 3 (a.3), and two
4
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Figure 1:
The L d and Kbm3 MHC molecules differ at nearly every polymorphic residue within the
antigen binding cleft (3,4). The darkened circles indicate the positions of these amino acid
differences within the binding cleft as viewed from above. The numbers indicate the position of
the amino acids with respect to the N-terminus (i.e.beginning) of the protein chain. The extreme
differences in residues presumably alters the array of peptides bound by the two molecules
through alteration of binding pockets as well as stenc interference (6).
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Figure 2:
A: Cartoon-type drawing of class I MHC molecule projecting from the cell membrane.
The drawing also shows the close association of the Prmicroglobulin molecule which is produced
by the transcription and translation of a separate gene.
B: Top view drawing of the antigen binding cleft. The drawing shows the N-terminus of
the cx.1 subunit leading into the antiparallel P sheet, and the direction of the strands within the
sheet.

c:

Side view drawing of the protein showing the termini of the protein, as well as the

direction of each fold. This drawing again shows the Prmicroglobulin in its close proximity to
the class I MHC molecule. The binding cleft is also clearly portrayed.

These figures taken from the text book Immunology (1992) by Janis Kuby (1).
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distal domains, termed alpha I and alpha 2 (al and (2). The latter domains combine to form
eight antiparallel

~

strands and two long a helices that form the bottom and sides, respectively, of

a cleft that binds short peptides (2). The function of the class I MHC molecules is to present
endogenously produced peptides on the cell surface within this peptide binding groove or cleft
(5). While the aI, a2, and a3 subunits are all encoded by the same set of genes and are one
continuous protein, the
Association with the

~2M

~2M

subunit is actually an associated protein encoded by a different gene.

subunit is required for class I MHC expression on the cell surface (I).

Class I MHC Function
MHC/peptide complexes are scanned by CD8+ cytotoxic T cells. Upon recognition of a
foreign peptide in association with a class I MHC molecule, CD8+ T cells lyse the infected cell and
keep the infection from spreading. This process is especially important in viral diseases and
cancers because the peptides produced within a viral-infected or transformed cell differ from those
produced in a normal cell.
Current dogma holds that there are a number of pockets within the peptide binding cleft
that determine the array of peptideswhich a particular MHC molecule can bind (6). Side chains
on the peptide must fit into and interact with these pockets to allow binding of the peptide within
the binding cleft through hydrogen bonds and van de Waals interactions (6). The pockets differ
between alleles, changing the peptide binding motif of each class I molecule.
T cell recognition occurs when a T cell receptor (TCR) makes contact with and binds to
an MHC/peptide complex forming a tn-molecular complex (Figure 3). The TCR is believed to
bind to parts of one or both a helices of the MHC molecule, as well as to the exposed side chains
of the peptide in the binding cleft (7,8). It has been previously shown that mutations that change
9
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Figure 3:
Representation of the trimolecular complex that forms during immune recognition by a T
cell receptor. The TCR binds to contact residues on the a. helices and the peptide held within the
binding groove. The formation of this trimolecular complex somehow signals the T cell to
become activated and lyse the cell.
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the side chains of the a helices that point up away from the binding cleft have no effect on the
peptide array bound by the MIlC molecule (9-12). Grandea and Pullen (9,10) have also
demonstrated that certain mutations along these side chains lead to an alloresponse by cytotoxic T
lymphocytes (CTLs), while others do not change the responsiveness of the CTLs. This leads to
our hypothesis that there are certain side chains off the a helices that act as contact residues for
the TCR during formation of the trimolecular complex, A study of different TCRs with the same
MIlC/peptide complex has shown that the contact residues are variable between TCRs (11). We
hope to show that a single TCR can have different contact residues depending on the complex it is
recognizing. Our hypothesis accounts for the different peptides needed in the clefts of the two
molecules to elicit the alloreactive T-cell response because it addresses the complex as a whole.

Methods
All work was done at the Mayo Graduate School in Rochester, Minnesota. The project
was accomplished May-August, 1994 and was continued during January, 1995. It was made
possible by the summer research program of the Mayo Graduate School, and funding for materials
came out of the grants from Dr. Larry R. Pease's lab.
Polymerase Chain Reaction (PCR)
PCR was carried out in a total volume of 100ul containing O.5ug of sample DNA,
100pmol of each primer oligonucleotide, 10ul of dNTP, 10ul of 10X 15mM Mg2+ PCR reaction
buffer, O.5ul ofTaq polymerase, and double distilled sterile H 20 (ddH20) to volume. Primers
were prepared on site in the Mayo molecular biology core facility, and were purified using NAP
10 desalting columns. After purification, they were eluted in ddH20 and their concentration
determined by optical density in a spectrophotometer. The thermal cycler file was set for a total of
12
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25 cycles consisting of a 94°C denaturing step of one minute, a 50°C annealing step of two
minutes, and a 72°C extension step ofthree minutes. In theory, each cycle will double the number
of copies of DNA with 100% accuracy. However, Taq polymerase does not have the ability to
proofread the strand as it duplicates and is prone to an error frequency of 0.25% (13). This
frequency is significantly higher than that observed by Ho et al. (14) in the development of site
directed mutagenesis by overlap extension, which they found to be 0.026%. In either case,
because of the possibility of mutations, constructs containing PCR products were carefully
checked for sequence fidelity against the known sequence of the molecules.
Genomic Ld DNA was contained in the bacterial expression vector plasmid pBR322, and
this was used as our source ofLd template. Oligonucleotide fragments ranging in length from 24
to 36 nucleotides were prepared with specific mismatches that would allow annealing during
PCR, but would introduce point mutations during the amplification. These mutations introduced
specific restriction sites within the introns before exon 2, between exons 2 and 3, and after exon 3
(Figure 4). Kbm3 containing the restriction sites had been prepared for previous studies in

the lab,

so it was not necessary to introduce these mutations.
Splicing by Overlap Extension (SOEing) by PCR
Another process for the introduction of point mutations, SOEing is often used for
changing bases in the middle of a stretch of bases (Figure 5). In this case, we wanted to change
an amino acid between our new restriction sites. Four primers were required, one at each end of
the DNA fragment (in this case, containing restriction sites), and two new ones with
complimentary sequences containing a substitution at the same location. Because of their
complimentary sequences, one allowed extension from it in the 5' direction, and the other

13
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Figure 4:
Structure of the expression vector SA? (3). The darkened boxes represent exons 2 and 3
which code for the 0.1 and 0.2 domains, respectively. It is within these two exons that the
mutations were made that define each ofthe constructs.
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Figure 5:

Explanation of the ISOEing" procedure for site-directed mutagenesis. Four primers are
used in a procedure that utilizes peR twice and results in the precise introduction of nucleotide
point mutations.
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terminated extension by annealing farther down the opposite strand. In addition, one of the two
previously mentioned restriction primers allowed extension and the other caused termination. In
the first step of the SOEing reaction, the S' restriction primer was paired with the 3' mutation
primer, while the S' mutation primer was paired with the 3' restriction primer. These two
reactions were run in separate tubes following standard PCR protocol. A procedure known as
Gene Clean (Bio 101) was then run on each ofthe reaction products. During this procedure,
Glassmilk bound the long strands ofDNA and held them while excess primers, short strands of
DNA «SO bases), and other reagents were decanted away. The DNA was then recovered by
eluting it off of the Glassmilk beads with SsoC water. Gene Clean was also important after
restriction digests to eliminate the short end fragments clipped off during the digest, and for
recovering DNA from agarose gels after separations.
. . Following Gene Clean, the products of the first reactions were mixed and a second round
ofPCR was run using only the two restriction primers. During the heating stage, the two double
stranded DNA molecules separated and mixed. Upon cooling at the annealing stage, some of the
reannealed molecules were annealed only by their short homologous overlap region (inserted
using the mutation primers). Taq polymerase then extended the two ends using the tails as
templates. The result was a single DNA molecule that spanned the two restriction sites
containing a specifically engineered point mutation. The second PCR step was required to obtain
the full stretch of DNA desired. This procedure introduced mutations at amino acids 6S, 72, 79,
d

138, 149, and lS8 in both the L and the Kbm3 DNA (Figure 6).

18
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Figure 6:
Positions of the mutated amino acid residues within the peptide binding groove. The
darkened circles represent relative positions of changes made using the "SOEing" method. The
changes in nucleotides resulted in conservative changes in the amino acid sequence (see Table 1).
The changes only alter side chains projecting away from the peptide binding groove and do not
affect the array of peptides that bind within the groove (8-12).

19
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Restriction Enzyme Digests
Most cuts were made using 0.5ug of DNA, 10% (1ul) of the appropriate buffer, 10 units
(luI) of the appropriate enzyme, and sterile water to bring the total volume to 10ul. Some digests
required a greater quantity ofDNA and thus adjustments in the above quantities. Enzymes and
buffers were purchased from Boehringer Mannheim, and the reactions were run at the
recommended optimum temperature for each enzyme.
Gel Electrophoresis
DNA fragments were separated based on size and charge using 1.5% agarose gels in TBE
buffer. TAE buffer was used when the DNA was to be recovered later using Gene Clean. A total
volume of20ul was loaded into each lane of the gel. This volume contained 0.25-0.5ug of DNA
and 5ul of ficoll tracking dye in sterile (double deionized) water. A charge of 90 volts for 2 hours
was usually sufficient for good separation, but the charge and duration varied depending on the
importance of resolution and on time constraints ofthe day. Ethidium bromide was mixed into
the gel before congealing to help visualize the DNA under ultraviolet light.
Transfections
Transfections into BW 5147 cells (thymoma or immortal thymus cells) were accomplished
using lipofectamine to create liposomes that could fuse to the cells and release the DNA contained
in the liposomes to the cell interior. Lipofectamine is a polycationic lipid that forms complexes
with DNA due to ionic interactions with the negatively charged phosphate groups (15). These
complexes have a net positive charge, allowing them to associate with and fuse to the charged cell
membrane (16). Upon fusion of the outer lipid layer to the plasma membrane, DNA is released to
the interior of the cell. The plasmid pRc/CMV was cotransfected along with each of the
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constructs as a selective marker. It contained a neomycin resistant gene and allowed selection of
successfully transfected cells in a media containing lmg/ml G4l8 (synthetic neomycin).
Presumably, any cell which integrated the pRc/CMV plasmid also integrated the desired construct
because the selection plasmid was added in limited quantities (lug construct:.5ug selective
plasmid). The transfections involved 3.0 x 106 cells which were left in contact with the liposomes
for five hours before new media was added. After a 24 hour recovery period, the media was
removed and replaced with the selection media containing G4l8. The cells were then split
periodically to keep them from becoming too dense in the flask, and the media was changed every
other day to select for the transfected cells.
An alternative transfection procedure was used for our second cell line, the mouse
lymphoma cells (L cells) which do not respond well to the above transfection method. Instead,
we used a calcium phosphate precipitation procedure to introduce the DNA into the cells. In this
procedure, 2M CaCh was mixed with the DNA constructs that we wanted to transfect along with
a cotransfectant plasmid called pHSV and left to stand for 20 minutes at room temperatur~ while
it formed a CaP04-DNA precipitate. The precipitate was then added to L cells that were plated at
a density of lxl0 4/cm2 . During the 4 hour incubation time, the DNA was endocytosed by the L
cells which were then washed free of leftover precipitate and given complete media. After a 48
hour recovery period, the complete media was replaced with HAT selection media.
Cells can synthesize nucleotides by either the de novo or salvage pathways. HAT
selection media contains aminopterin which blocks the de novo synthesis of nucleotides, forcing
the cell to use the salvage pathway. This salvage pathway requires hypoxanthine and thymidine as
well as two enzymes. While the HAT media contains the hypoxanthine and thymidine, L cells are
22
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not capable of utilizing this pathway because of an enzyme deficiency. The transfected cells were
separated from untransfected cells because the cotransfected plasmid pHSV contained the genes
for the enzymes needed to utilize the salvage pathway. Cells that endocytosed pHSV also
presumably endocytosed the plasmid construct. These cells survived in the HAT media and were
harvested for analysis.
Cytotoxic T Lymphocyte Assays
CTL assays involved labeling target cells with SlCr and subjecting them to effector cells.
s1

Cells were labeled by adding Na2 Cr04 and incubated for I hour, during which time the cells
absorbed the radiolabel. Once internalized, the radiolabel was only released in the event of cell
death, either by lysis or spontaneous death. Following the labeling, effector cells were added to
each well and the mixture was incubated for 5 hours. After incubation, the wells of the plate were
harvested and counted in a gamma counter. Spontaneous (background) release of chromium was
measured in control wells that did not have effector cells added. Total lysis was determined by
the addition of a detergent (Triton X-I 00) to a set of wells also containing only target cells.'
Specific lysis was then calculated using the formula:

% specific lysis

= (cpm released by CTL - cpm of spontaneous release) x 100
(cpm released by detergent - cpm of spontaneous release)

Where cpm= counts per minute
We added an additional step when T2 cells were used because they are peptide-deficient
and cannot transport MHC molecules with bound peptide to the cell surface. Instead, they have
empty peptide binding sites on their MHC molecules. Before adding the effector cells, T2 cells
were incubated for one hour with a known peptide to sensitize them. We used a peptide
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designated p2Ca on the Ld constructs, and one designated 2CKbm3 E on the Kbm3 constructs. Our
data suggest these peptides sensitize the respective molecules to 2C TCR recognition (Figure 7).
DNA Sequencing
After the PCR steps, it was necessary to sequence the mutated segment of each construct
to make sure the proper mutation was introduced and no new mutations arose. The first step was
to transform bacteria with the constructs and culture them overnight. After lysing the bacteria, a
plasmid preparation was done and the plasmids were ready for sequencing.
Using oligo primers that bind near the region desired, T7 DNA polymerase synthesized a
new strand of DNA until the termination bases were added. Different strands began replication at
different times and rates due to reaction kinetics, and ended up being different lengths when the
termination base was added. The product was then separated by polyacrylamide gel
electrophoresis (pAGE) in a fashion similar to the previously mentioned electrophoresis. One of
the bases added to the strands during synthesis was 3SS labeled adenine. After drying, the gel was
exposed to X-ray film and bands showed up after developing. It was then possible to read the
sequence from the gel. This process was tedious and yielded sequences of about 200 bases per
primer. Because of the efficiency (350-400 bases per primer) some of the sequencing was done in
the automated sequencer at the Mayo molecular biology core facility. The manual sequencing
was done to elucidate problems from the automated sequencer such as compressions and
unknown bases in the sequence.
Fluorescence Activated Cell Sorting (FACS)
FACS uses antibodies tagged with fluorescent compounds to sort cells based on the
presence or absence of fluorescence when struck with laser light. In our sorts, the antibodies
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Figure 7:
A: Results of the chromium release assay using T2 transport deficient cells and peptide
p2Ca. The peptide sensitizes T2Ld cells to 2C TCR recognition in a concentration dependent
manner while showing no such sensitization on T2Kbm3 cells.

B: Results of the chromium release assay using T2 transport deficient cells and the
2CKbm3E peptide. This peptide sensitizes T2Kbm3 cells to 2C TCR recognition in a concentration
dependent manner while showing no such sensitization on T2Ld cells.
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were specific for the a 3 domain of the MHC class I molecule. We used a primary monoclonal
antibody (designated 28-14-8), to bind to the a 3 domain. We then used a secondary antibody
produced in a goat against the Fe region of murine antibodies. This secondary antibody was
tagged with a compound called FITC that fluoresces in the green spectrum when struck by the
laser.
Along with presence or absence of surface molecules, it was also possible to differentiate
between live and dead cells, as well as cells of different sizes. These were determined by
examining the forward and side scatter ofthe light. The larger the cell, the more light passes
through it to the detector, and the higher its forward scatter. Side scatter is essentially the
opposite of forward scatter in that the light that does not pass through the cell is deflected and
picked up by another sensor. Granular cells, collapsed cells, and various noncellular particles
generally have a high side scatter.
The last compound we used was propidium iodide (PI), which is absorbed by dead cells
and fluoresces in the orange spectrum when struck by laser light. Between forWard scatter, side
scatter, PI, and fluorescence, it was possible to focus on fairly precise populations of cells and
sort them out of a larger population.

Materials
SA7 Expression Vector
SA7 is a modified pUC 18 expression vector containing a 1.8-kb Xbal fragment from the
murine H-2Kb gene, and a 2.S-kb BamID fragment from the H-2Ld gene (3)(Figure 4). The Xbal
fragment, which encodes the a 1 and a2 domains ofthe class I MHC molecule, has been modified
to introduce restriction sites that flank the domains. This allows excision of either domain
28
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independently of the other, which was important in this project. The 2.5-kb BamHI fragment
encodes the extracellular 0.3 domain, the transmembrane domain, and the cytoplasmic domain of
the L d molecule. This was included to allow determination of expression levels of the mutant
molecule on the cell surface using the monoclonal (mAb) 28-14-8. The antibody binds to the 0.3
domain ofLd .
In making the constructs for this project, the Sall and HindlII sites flanking the 0.1 domain
or the HindIII and Xhol sites flanking the 0.2 domain were used to excise the respective domain
so it could be replaced with the desired mutated domain. In the case of the Ld constructs, when
one domain was replaced with a mutated domain, the other was replaced by the wild-type L d
domain (i.e. both Kb domains were changed to Ld domains). In the case of the Kbm3 constructs,
the 0.1 domain of5A7 had to be replaced because of the mutations at amino acids 77 and 89 that
defihed the Kbm3 mutant MHC molecules from the wild-type Kb molecules. The 0.2 domain could
be left unchanged unless a mutation was desired within the domain, as was the case with the 138,
149, and 158 mutants.
Origin of the 2C TCR
The 2C TCR was positively selected in an H_2 b haplotype mouse which had K b and

Db

alleles of the MHC genes. In theory, it should have only responded to these two alleles during
antigen recognition (17). However, this did not occur. The 2C TCR was found to be alloreactive
on both the K bm3 allele (a mutant ofthe Kb allele) from H_2 mice, and the Ld allele from H_2d
b

mice (17). The ability of the TCR to recognize the mutant molecule is not surprising because of
the large degree of homology between the molecules that was discussed earlier. The ability to
recognize an allele that was not present during selection, however, is quite intriguing. The means
29
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by which this TCR accomplishes this dual recognition is not understood and is the focus of this
study.
Cells
The BW cells were purchased from the American Type Culture Collection (Bethesda,
MD). 2C T cells were originally derived by Dennis Loh (Washington University) and are now
isolated from 2C transgenic mice that are maintained in the Mayo Clinic animal facility. T2 cells
were obtained from Peter Crestwell (Yale University).
Results and Discussion

Construct Results
Before we could test the effects of mutations on T cell recognition, it was first necessary
to introduce the mutations by using the ItSOEinglt procedure mentioned above. At the end of the
summer we had determined that we had successfully inserted the mutations at amino acid
positions 72, 79, 138, 149, and 158 ofKbm3 and amino acid positions 72, 149, and 158 ofLd. This
gave us three pairs of mutants to transfect into L cells (a lymphoma line), in an effort to show
differential recognition between Kbm3 and Ld mutants. Unfortunately, the transfections failed
during my absence between August, 1994 and January, 1995. Upon my return in January, we
were able to successfully sequence the K

bm3

65 and Ld79 mutants and had four sets of mutants to

transfect. Because the first attempt at transfection had failed for an unknown reason, we opted
for an alternative cell line that had worked well in the past. We transfected the constructs with
mutations at amino acid 72, 79, 149, and 158 into BW5147 cells. The outcome of these
transfections is not yet known.
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As for the remaining two Ld mutations at amino acid 65 and 138, there were some
unforeseen problems. When we sequenced several clones (from different colonies on a streak
plate) of the 138 mutant, we found they all shared a single mutation. We hypothesized that this
could have been a point mutation arising in an early cycle ofPCR and, therefore, showed up in a
large proportion of the colonies. This led us to a second attempt at constructing the mutant.
Surprisingly, we found the same mutation upon analysis of sequences from the second attempt.
Closer analysis of the position ofthe mutation showed that it was in a position that our
manufactured fusmer should have occupied. Although we requested the proper primer sequence,
it seemed to have an improper base in it. Either it was constructed improperly, or some
biochemical process had mutated the oligo. We were forced to reorder the oligo from the Mayo'
molecular biology core facility and start over. Unfortunately, it was too late in the month to begin
when we received the oligo.
The Ld65 mutant is a bit more complex problem. When we sequenced the mutants, we
found that half of the sequence was correct, while the other half (the half of exon 2 that is 5' to
our fusmer) was completely wrong. When we entered this nonsense sequence into Genebank,
which is a database of gene sequences, it matched it to a region of the E. coli genome that codes
for glutamine synthetase. It seems that the fusmer is homologous to this region of the E. coli
genome and can efficiently prime its replication during PCR. PCR requires very small amounts of
template DNA for the primers to bind and there seems to be enough genomic E. coli template
mixed in with the plasmid template to be recognized and amplified during PCR. Because we need
to keep the fusmer sequence to introduce the proper mutation, changing primers is not an option.
The next step is to obtain a cleaner plasmid preparation. Thus far, most of the plasmid
31
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preparations were done using a kit from Promega (Madison, WI), which gives good plasmid yield
and minimal genomic DNA contamination. Unfortunately, this minimal contamination is still too
much in this case. In the future, the DNA will have to be purified further using a cesium chloride
gradient and ultracentrifugation, which will separate the plasmid DNA from the genomic DNA.
Once the separation is complete, the purified plasmid can then be used with the same fusmer in
the "SOEing" reaction.
Transfections are Still in Progress
After extensive testing, Kathy Allen, a technician in the Pease lab, detennined that the
pHSV cotransfectant plasmid was somehow degraded. This explained why our transfection had
not survived the selection process at the end of the summer. If the plasmid is degraded, it will not
be properly integrated into the host cell DNA and will not be expressed. Without the
cotransfected plasmid, the cells will die upon addition of HAT media. Because the selection
process is faster and leads to clonal populations of cells expressing the transfected protein, we
opted to attempt the L cell transfections again using new pHSV. Preliminary data suggest that
the 158 mutants of both alleles are proliferating under selection. The beauty ofL cells is that,
unlike the BW cells, they are an adherent cell line and will settle individually and begin to divide
mitotically to form small colonies. These colonies can then be isolated much like bacterial
colonies to give a clonal population. In contrast, BW cells float in the media while dividing and a
cell sort must then be done to isolate a majority of the expressing cells. These must then be
sorted again, after a few days of proliferation, to yield a population in which the majority of cells
express the protein transfected, but which is not clonal. The L cell procedure is quicker and leads
to more uniform cultures which is why it was employed in the beginning.
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Defining the CTL Assays
Although we were not able to begin the CTL assays on our transfected cells, we were able
to run some preliminary tests to determine which of our 2C T cell lines to use, while better
defining the system we will be dealing with. There were several 2C T cell lines available in the lab
that were characterized and isolated at different times. We found the lines 2C82793 and 2C32494
to be most useful in terms of killing specificity, recovery time, and optimal usage time (i.e. the
amount of time needed after stimulation to obtain specific killing). T cell lines must be stimulated
weekly with spleen extract to provide them with the targets and cytokines needed for their
continued

prolifer~tion.

The two lines we used gave optimal killing between four and six days

after stimulation. Following this period, cells that were not stimulated again were not active
enough to kill at an acceptable level. Conversely, using the cells before the four days had elapsed
resulted in a high rate of nonspecific target cell lysis due to the hyper-activation of the cells.
Other cell lines in the lab required greater periods of time after stimulation before they could be
used in an assay, and were deemed unacceptable due to the short time frame of this project
Determination of Peptides Used
Along with determining the T cell lines to employ, we were also able to support data
showing that the 2C TCR recognizes the octapeptide p2Ca in the context of the L d class I MIlC
molecule (18). T2 cells have been previously transfected in our lab with both the K bm3 and the Ld
MIlC molecules. These are peptide transport deficient cells that express "empty" class I
molecules on their surface. By adding exogenous p2Ca into the empty binding cleft, we were able
to show a high degree of specific lysis of the T2Ld cells while observing a low killing rate of the
T2Kbm3 cells (Figure 7A). As a control, we also assayed T2 cells without the addition of
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exogenous peptide and, as expected, observed a low specific lysis. We have also shown that the
proposed K bm3 peptide 2CKbm3E is in fact involved in the alloresponse by the 2C TCR. Michelle's
thesis work has led her to isolate a potential p2Ca counterpart, 2CKbm3 E, which has produced
similar results with T2Kbm3 cells as p2Ca has produced with T2Kd (19)(Figure 7B). These data
show that the two MIlC molecules are not only very different in their amino acid sequence, but
also in the peptide they express (Table 1). This is interesting in terms of defining the different
types of alloresponses observed.
Mechanisms of Allorecognition Studied
Allorecognition often involves the recognition of highly different MIlC/peptide complexes
by the same TCR. However, this is not the only type of alloresponse characterized. It has been
shown that alloresponses occur in situations where a single amino acid change has occurred with
no affect on the array of peptides bound (9,10). This small change has affected the interaction
between the 'fCR and the MIlC/peptide complex leading to an alloresponse. It is also apparent
that conformational changes in the MIlC molecule or the peptide in the binding groove can cause
an alloresponse (10,20), which occurs when a mutation causes a slight perturbation of the
complex's shape. There may be several other mechanisms by which alloreactivity occurs, but
these are the ones that are well

kno~.

The system employed in this study is of interest because it involves two of the previously
mentioned mechanisms. It is obvious that the Ld allele is quite different from the 2C training
molecule (Kb). Therefore, it is believed that a different epitope, but one similar in structure to the
positively selecting epitope, may be recognized to allow for the alloresponse. The recognition of
a different epitope would require the TCR to encounter the MIlC/peptide complex at a different
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Table 1. Sequences of oligonucleotide primers and peptides used throughout the project.
Oligonucleotide Sequence

Position·

Structural Change

Intron 1
Intron 2
Intron 3
Intron 3

SaIl site
HindIlI site
Xhol site (Kbm3)
Xhol site (Ld)

Restriction Primers
5'GCGTCCTCGGGTCGACCACCGGACCC 3'
5'CCCAAGTCCAAGCTTCGGGAACAG 3'
5'GGCTAAGCACTCTCGAGGGAGAAGGCT 3'
5'GGCTGGGCCCTCTCGAGGGAGAAGGCT 3'
Kbm3 Fusmers
5'GAGCGGGAGACAGACAAAGCCAAGGGC 3'
5'AAGGGCAATGAGATGAGTTTCCGAGTG 3'
5'CGAGTGGACCTGATGACCCTGCTCGGC 3'
5'ACGGCGGCGGACAAGGCGGCGCTGATC 3'
5'CACAAGTGGGAGATGGCTGGTGAAGCA 3'
5'GAGAGACTCAGGACCTACCTGGAGGGC 3'

Amino Acid 65
Amino Acid 72
Amino Acid 79
Amino Acid 138
Amino Acid 149
Amino Acid 158

Gln~Asp
Gln~Met
Arg~Met
Met~Lys
Gln~Met
Ala~Thr

Ld Fusmers
5'GAGCGGATCACGGACATCGCCAAGGGC 3'
5'AAGGGCCAGGAGATGTGGTTCCGAGTG 3'
5'CGAGTGAACCTGATGACCCTGCTCGGC 3'
5'ACGGCGGCGGACAAGGCGGCGCAGATC 3'
5'CGCAAGTGGGAGATGGCTGGTGCTGCA 3'
5'GAGTATTACAGGACCTACCTGGAGGGC 3'
Peptides Used
p2Ca: Allows recognition ofLd by the 2C TCR.
LSPFPFDL or Leu-Ser-Pro-Phe-Pro-Phe-Asp-Leu
2CKbm3E: Allows recognition ofKbm3 by the 2C TCR.
EQYKFYSL or Glu-Gln-Tyr-Lys-Phe-Tyr-Ser-Leu

35

Amino Acid
Amino Acid
Amino Acid
Amino Acid
Amino Acid
Amino Acid

65
72
79
138
149
158

Gln~Asp

Gln~Met
Arg~Met
Met~Ly~
Gln~Met
Ala~Thr
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angle or orientation. The training epitope and the alloepitope would then be degenerate
recognition sites occurring at different points in their respective complexes. Conversely, the K bm3
allele is very similar to the parent Kb molecule and it is believed that the positively selecting
epitope is the same epitope that leads to the alloresponse. A slight increase in affinity by the TCR
for the MHC molecule would allow allorecognition and CTL activity. This mutant of the Kb
molecule differs at two amino acids from the parent molecule, only one of which is associated
with the binding cleft (Figure 8). Substitution at position 77 presumably alters the conformation
of the molecule and accounts for the increased affinity and alloreactivity by the 2C TCR (3).
According to research still in progress (Tallquist, personal communication), it is highly probable
that the Kb and Kbm3 molecules both contain the same peptide recognized by the 2C TCR. This
evidence further corroborates the idea that it is the same epitope that is recognized in both
bm3

molecules. If this is the case, the allorecognition ofthe K

molecule occurs due to the high

degree of siniilarity between the training molecule and the allomolecule, while the L d alloresponse
is directed at the extreme difference of the peptide/MHC complex. This illustrates two di~erent
forms of allorecognition. One form is characterized by an MHC/peptide complex that is distinct
from self, while the other is defined by a minor structural perturbation that causes a deviation
from self that results in allorecognition (19).
Accomplishments of the Project
Once we obtain results from the CTL assays of our transfected mutant molecules, we hope
to support our hypothesis of differential epitope recognition. By showing that the epitope for
d

bm3

allorecognition differs between the L and K

molecules, we will show, in an indirect manner,
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Figure 8:
Location of the two point mutations that characterize the Kbm3 mutant molecule. The
mutation at amino acid position 77 results in the allorecognition of this molecule by the 2C TCR
which was trained on the Kb parent molecule (3).
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that the epitopes are also different between the Ld and Kb molecules. This will follow because of
the K bm3 work done by Pullen et. al. (3).
This project is not of the proper scope to fully address positive selection. However, if our
hypothesis is correct, we will further support recent studies (19) implying that the same peptide
that positively selects the 2C TCR during development is responsible for a hierarchy of
alloresponses in mutant molecules of the Kb allele. This suggests a new strategy for the isolation
of molecules that govern positive selection during fetal development. In this strategy,

mutant~

would first be characterized, an allorecognition system determined, and the peptide isolated using
HPLC fractionation.
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